Rhea-AI Summary
Semnur Pharmaceuticals (OTC: SMNR) signed a binding term sheet for a proposed $100 million strategic equity investment from iHolding Group LLP at an expected $10.00 per share, or about 10 million new common shares.
According to Semnur, proceeds would fund the Phase 3 program for SEMDEXA (SP-102), broader pipeline advancement, product development and commercialization, acquisitions and partnerships, working capital, IP expansion, and other corporate purposes. Closing depends on due diligence, definitive agreements, board and regulatory approvals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.00%
Tags
FAQ
What is the current stock price of Semnur Pharms (SMNR)?
Semnur Pharms (SMNR) last closed at $0.3000.
What is the market cap of Semnur Pharms (SMNR)?
The market cap of Semnur Pharms (SMNR) is approximately $69.1M.